EMPA-RESPONSE (Completed)
Randomized, double blind, placebo controlled, multicenter pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure
- Medicine
- empagliflozin
- Population
- Heart failure
- Phase
- II
- Starting year
- 2017